Calyxo

Calyxo, Inc. is a medical device company based in Pleasanton, California, founded in February 2016. The company focuses on enhancing the treatment and care for patients with kidney stones, operating within the urology sector. Calyxo aims to transform kidney stone treatment by providing innovative solutions that help urologists achieve safe and effective clinical outcomes. The company's main product is the CVAC System, recognized as the world's first all-in-one kidney stone treatment system. This technology addresses the healthcare resources and costs associated with kidney stone disease, which affects many individuals. Calyxo's mission is to deliver solutions that allow for efficient, one-time treatments, ensuring peace of mind for both patients and healthcare providers. Calyxo has raised a total of $97.61 million in funding, with its most recent round bringing in $50 million. The leadership team comprises experienced professionals in medical device development and healthcare, committed to improving patient outcomes in the kidney stone treatment landscape.